ChemoCentryx, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Four
ChemoCentryx, Inc. had Lessee, Operating Lease, Liability, to be Paid, Year Four of $8.17 million as of 2022-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour · last filed 2022-08-08
- 2022-06-30: Lessee, Operating Lease, Liability, to be Paid, Year Four $8.17M.
- 2022-03-31: Lessee, Operating Lease, Liability, to be Paid, Year Four $8.17M.
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Four $7.95M.
- 2021-09-30: Lessee, Operating Lease, Liability, to be Paid, Year Four $7.95M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year Four |
|---|---|
| 2022-06-30 | $8.17M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $8.17M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $7.95M 10-K · filed 2022-03-01 |
| 2021-09-30 | $7.95M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $7.95M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $7.94M 10-Q · filed 2021-05-03 |
| 2020-12-31 | $7.72M 10-K · filed 2021-03-01 |
| 2020-09-30 | $7.52M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $7.52M 10-Q · filed 2020-08-10 |